RA-FLS have been confirmed to undergo TGF-β1-mediated EMT, with decreased E-cadherin and increased N-cadherin, vimentin, and α-SMA through the Smad2/3 pathway [190]. The gene discussed is CDH1; the disease is rheumatoid arthritis.